EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comparative Evaluation of Commercial Protein A Membranes for the Rapid Purification of Antibodies

Joshua Osuofa iD, Scott M Husson iD

Membranes · 12.05.2023 · 13 (5) · 511

DOI: 10.3390/membranes13050511 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Membranes, online erschienen am 12.05.2023. Verfasst von Joshua Osuofa und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical and Biomolecular Engineering, Clemson University, Clemson, SC 29634, USA. Die Arbeit wurde bisher 37-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIGMS NIH HHS, National Institute of General Medical Sciences of the National Institutes of Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Protein A chromatography is ubiquitous to antibody purification. The high specificity of Protein A for binding the Fc-region of antibodies and related products enables unmatched clearance of process impurities like host cell proteins, DNA, and virus particles. A recent development is the commercialization of research-scale Protein A membrane chromatography products that can perform capture step purification with short residence times (RT) on the order of seconds. This study investigates process-relevant performance and physical properties of four Protein A membranes: Purilogics Purexa™ PrA, Gore® Protein Capture Device, Cytiva HiTrap™ Fibro PrismA, and Sartorius Sartobind® Protein A. Performance metrics include dynamic binding capacity, equilibrium binding capacity, regeneration-reuse, impurity clearance, and elution volumes. Physical properties include permeability, pore diameter, specific surface area, and dead volume. Key results indicate that all membranes except the Gore® Protein Capture Device operate with flow rate-independent binding capacities; the Purilogics Purexa™ PrA and Cytiva HiTrap Fibro™ PrismA have binding capacities on par with resins, with orders of magnitude faster throughput; and dead volume and hydrodynamics play major roles in elution behavior. Results from this study will enable bioprocess scientists to understand the ways that Protein A membranes can fit into their antibody process development strategies.

Schlagwörter

Stichwörter der Autor:innen

Protein Abioprocessing industrydynamic binding capacityelution volumeimpurity clearancemembrane chromatographymonoclonal antibodypermeability

Autor:innen und Institutionen

  • Department of Chemical and Biomolecular Engineering, Clemson University, Clemson, SC 29634, USA.

ORCID-Profile: Joshua Osuofa, Scott M Husson

Förderung

  • NIGMS NIH HHS
  • National Institute of General Medical Sciences of the National Institutes of Health

Zitieren

APA

Osuofa, J., & Husson, S. M. (2023). Comparative Evaluation of Commercial Protein A Membranes for the Rapid Purification of Antibodies. Membranes, 13(5), 511. https://doi.org/10.3390/membranes13050511

Vancouver

Osuofa J, Husson SM. Comparative Evaluation of Commercial Protein A Membranes for the Rapid Purification of Antibodies. Membranes. 2023;13(5):511. doi:10.3390/membranes13050511

BibTeX
@article{Osuofa2023,
  author = {Osuofa, Joshua and Husson, Scott M},
  title = {Comparative Evaluation of Commercial Protein A Membranes for the Rapid Purification of Antibodies},
  journal = {Membranes},
  year = {2023},
  volume = {13},
  number = {5},
  pages = {511},
  doi = {10.3390/membranes13050511}
}
Kostenlos starten →